Relief Therapeutics Holding AG (RLFTF)

[ratna1]

Just to make sure that I expressed myself correctly: I am NOT Prof. Müller-Quernheim and did not write that Article for the NEW ENGLAND JOURNAL OF MEDICINE!
I only used it for reference as it is break through research and I cannot believe that RELIEF is not using it with the FDA to document the established use and safety profile of AVIPTADIL in clinical settings worldwide.
After all they are aware of it since they do buy out the company that provided the inhalation-devices....

I am equally perplexed that this research is hardly known in other departments - like intensive care units - here at the university teaching hospital....
After all an article in the NEW ENGLAND JOURNAL OF MEDICINE is the gold standard of Medicine - if this peer reviewed and published it is almost like adding a chapter to the Bible